» Articles » PMID: 4076001

How Dangerous Are Diuretics?

Overview
Journal Drugs
Specialty Pharmacology
Date 1985 Dec 1
PMID 4076001
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The proposal that thiazide diuretics may increase cardiovascular risk receives no support from recent data. Current evidence does not indicate that diuretic-induced hypokalaemia is associated with increased ventricular arrhythmias. This evidence includes continuous electrocardiographic monitoring--which is the most sensitive technique for quantitating cardiac arrhythmias. In contrast to earlier reports, more recent studies found no evidence for increased arrhythmias during the period of hypokalaemia, or for decreased arrhythmic activity after correction of hypokalaemia. Similarly, studies claiming increased sudden death in patients on diuretic treatment have not been substantiated by the results of other large-scale trials. Elevation of serum cholesterol concentrations with thiazide appears to be a short term phenomenon since most studies indicate the elevation reverts to baseline during long term treatment. Thiazide diuretics remain as one of our most effective antihypertensive agents. Fears of their increasing the incidence of ventricular arrhythmias due to hypokalaemia, or constituting a risk factor for atherosclerosis by elevating serum cholesterol concentrations, appear largely unsubstantiated.

Citing Articles

Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.

Papademetriou V J Clin Hypertens (Greenwich). 2006; 8(2):86-92.

PMID: 16470076 PMC: 8109414. DOI: 10.1111/j.1524-6175.2005.04722.x.


Do non-potassium-sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence.

Hoes A, Grobbee D, Peet T, Lubsen J Drugs. 1994; 47(5):711-33.

PMID: 7520854 DOI: 10.2165/00003495-199447050-00002.


The elderly patient. A special case for diuretic therapy.

Hyams D Drugs. 1986; 31 Suppl 4:138-53.

PMID: 3525088 DOI: 10.2165/00003495-198600314-00018.


Should the costs of development inhibit research into new antihypertensive drugs?.

Robertson J Cardiovasc Drugs Ther. 1989; 3(5):757-9.

PMID: 2518681 DOI: 10.1007/BF01857627.


Thiazides in the 1990s.

Orme M BMJ. 1990; 300(6741):1668-9.

PMID: 2202441 PMC: 1663293. DOI: 10.1136/bmj.300.6741.1668.

References
1.
. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA. 1982; 248(16):2004-11. View

2.
Madias J, Madias N, Gavras H . Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension. Arch Intern Med. 1984; 144(11):2171-6. View

3.
Michelson E, Morganroth J . Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording. Circulation. 1980; 61(4):690-5. DOI: 10.1161/01.cir.61.4.690. View

4.
Dyckner T, Wester P . Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am Heart J. 1979; 97(1):12-8. DOI: 10.1016/0002-8703(79)90108-x. View

5.
Kassirer J, Harrington J . Diuretics and potassium metabolism: a reassessment of the need, effectiveness and safety of potassium therapy. Kidney Int. 1977; 11(6):505-15. DOI: 10.1038/ki.1977.67. View